Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivatives. 1982

T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
August 1985, Chemical & pharmaceutical bulletin,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
January 1996, Medicinal research reviews,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
January 1986, Cancer chemotherapy and pharmacology,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
December 1979, Bollettino chimico farmaceutico,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
August 2009, Molecules (Basel, Switzerland),
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
November 1990, Chemical & pharmaceutical bulletin,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
December 1982, Chemical & pharmaceutical bulletin,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
February 1984, Chemical & pharmaceutical bulletin,
T Kametani, and K Kigasawa, and M Hiiragi, and K Wakisaka, and K Nakazato, and K Ichikawa, and K Fukawa, and O Irino, and N Nishimura, and T Okada
October 1974, Gan,
Copied contents to your clipboard!